The C3-factor can be phosphorylated at numerous different sites, which expectedly affect its structural properties and control functional activity; however, the consequence of such PTMs introduction is uncertain due to insufficient attention to the role of C3 phosphorylation in cancer pathophysiology. Here, C3 is linked to cancer.